Net Cash Provided by (Used in) Operating Activities |
-55.7M |
USD |
-213% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
58.9M |
USD |
|
Q1 2025 |
Q1 2025 |
Common Stock, Shares, Issued |
83.5M |
shares |
+18.9% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
45.1M |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
15.8M |
USD |
-19.2% |
Q2 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
15.2M |
USD |
-6.1% |
Q1 2025 |
Q1 2025 |
Deferred Income Tax Expense (Benefit) |
-471K |
USD |
-90.1% |
Q2 2025 |
Q2 2025 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2023 |
Q3 2023 |
Additional Paid in Capital |
816M |
USD |
+16.6% |
Q2 2025 |
Q2 2025 |
Interest Expense |
60.5M |
USD |
-3.66% |
Q2 2025 |
Q2 2025 |